Natural products from traditional Chinese medicine for the prevention and treatment of heart failure: progress and perspectives

被引:32
作者
Xu, Linhao [1 ,2 ]
Chen, Liuying [3 ]
Gu, Gaoyang [3 ]
Wang, Yi [4 ]
Xu, Yizhou [1 ]
Zhong, Yigang [1 ]
机构
[1] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Dept Cardiol, Sch Med, Hangzhou 310006, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Translat Med Res Ctr, Sch Med, Hangzhou 310006, Zhejiang, Peoples R China
[3] Zhejiang Chinese Med Univ, Hangzhou 310053, Zhejiang, Peoples R China
[4] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310009, Zhejiang, Peoples R China
关键词
Natural products; Chinese herb; Heart failure; Cardiac hypertrophy; Inflammation; fibrosis; Oxidative stress; Myocardial apoptosis; ASTRAGALOSIDE IV PROTECTS; PATHOLOGICAL CARDIAC-HYPERTROPHY; INHIBITING OXIDATIVE STRESS; ACUTE MYOCARDIAL-INFARCTION; TANSHINONE IIA PROTECTS; NECROSIS-FACTOR-ALPHA; DOUBLE-BLIND; DIASTOLIC FUNCTION; HYDROGEN-PEROXIDE; SHENMAI INJECTION;
D O I
10.31083/j.rcm2302060
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure (HF) is the end stage of several cardiovascular diseases with high mortality worldwide; however, current chemical drugs have not beneficial effect on reducing its mortality rate. Due to its properties of multiple targets components with multiple targets, natural products derived from traditional Chinese medicine (TCM) have exerts unique effects on the amelioration of the clinical symptoms of HF, yet, TCM is not widely used in the clinic since the potential therapeutic targets have not been fully investigated. Therefore, in this review, we briefly summarized the pathophysiological mechanism of HF and reviewed the published clinical evaluations of TCM and natural products from Chinese herbs to treat HF. Then, the therapeutic potential and the underlying mechanisms by which the natural products from Chinese herb exert their protective effects were further summarized. We concluded from this review that natural products from Chinese herbs have been shown to be more effective in treating HF by targeting multiple signaling pathways, including anticardiac hypertrophy, antifibrotic, anti-inflammatory, antioxidative and antiapoptotic activities. However, the major limitations of these compounds is that there are a lack of large scale, multicenter, randomized and controlled clinical trials for their use in treatment of HF, and the toxic effects of natural products from Chinese herbs also needed further investigation. Despite these limitations, further clinical trials and experimental studies will provide a better understanding of the mechanism of natural products from Chinese herbs and promote their wide use to treat HF.
引用
收藏
页数:18
相关论文
共 147 条
[1]   Acute myocardial infarction and heart failure: Role of apoptosis [J].
Abbate, Antonio ;
Bussani, Rossana ;
Amin, Mitesh S. ;
Vetrovec, George W. ;
Baldi, Alfonso .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2006, 38 (11) :1834-1840
[2]   Reappraising the role of inflammation in heart failure [J].
Adamo, Luigi ;
Rocha-Resende, Cibele ;
Prabhu, Sumanth D. ;
Mann, Douglas L. .
NATURE REVIEWS CARDIOLOGY, 2020, 17 (05) :269-285
[3]   ALTERATIONS IN SARCOPLASMIC-RETICULUM GENE-EXPRESSION IN HUMAN HEART-FAILURE - A POSSIBLE MECHANISM FOR ALTERATIONS IN SYSTOLIC AND DIASTOLIC PROPERTIES OF THE FAILING MYOCARDIUM [J].
ARAI, M ;
ALPERT, NR ;
MACLENNAN, DH ;
BARTON, P ;
PERIASAMY, M .
CIRCULATION RESEARCH, 1993, 72 (02) :463-469
[4]   Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction [J].
Armstrong, Paul W. ;
Pieske, Burkert ;
Anstrom, Kevin J. ;
Ezekowitz, Justin ;
Hernandez, Adrian F. ;
Butler, Javed ;
Lam, Carolyn S. P. ;
Ponikowski, Piotr ;
Voors, Adriaan A. ;
Jia, Gang ;
McNulty, Steven E. ;
Patel, Mahesh J. ;
Roessig, Lothar ;
Koglin, Joerg ;
O'Connor, Christopher M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (20) :1883-1893
[5]   Alterations in ryanodine receptors and related proteins in heart failure [J].
Ather, Sameer ;
Respress, Jonathan L. ;
Li, Na ;
Wehrens, Xander H. T. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2013, 1832 (12) :2425-2431
[6]   Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy A Randomized Clinical Trial [J].
Bakris, George L. ;
Agarwal, Rajiv ;
Chan, Juliana C. ;
Cooper, Mark E. ;
Gansevoort, Ron T. ;
Haller, Hermann ;
Remuzzi, Giuseppe ;
Rossing, Peter ;
Schmieder, Roland E. ;
Nowack, Christina ;
Kolkhof, Peter ;
Joseph, Amer ;
Pieper, Alexander ;
Kimmeskamp-Kirschbaum, Nina ;
Ruilope, Luis M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (09) :884-894
[7]   Anti-tumour necrosis factor-α therapy in heart failure:: Future directions [J].
Balakumar, Pitchai ;
Singh, Manjeet .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 99 (06) :391-397
[8]   Role of cytokines and inflammation in heart function during health and disease [J].
Bartekova, Monika ;
Radosinska, Jana ;
Jelemensky, Marek ;
Dhalla, Naranjan S. .
HEART FAILURE REVIEWS, 2018, 23 (05) :733-758
[9]   Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study [J].
Bavendiek, Udo ;
Berliner, Dominik ;
Davila, Lukas Aguirre ;
Schwab, Johannes ;
Maier, Lars ;
Philipp, Sebastian A. ;
Rieth, Andreas ;
Westenfeld, Ralf ;
Piorkowski, Christopher ;
Weber, Kristina ;
Haenselmann, Anja ;
Oldhafer, Maximiliane ;
Schallhorn, Sven ;
von Der Leyen, Heiko ;
Schroeder, Christoph ;
Veltmann, Christian ;
Stoerk, Stefan ;
Boehm, Michael ;
Koch, Armin ;
Bauersachs, Johann ;
Tebbe, Ulrich ;
von Haehling, Stephan ;
Haass, Markus ;
Anker, Stefan ;
Mohacsi, Paul ;
Polzl, Gerhard ;
Trampisch, Helmut ;
Zimmermann, Silke ;
Neuhaus, Barbara .
EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (05) :676-684
[10]   ECM remodeling in hypertensive heart disease [J].
Berk, Bradford C. ;
Fujiwara, Keigi ;
Lehoux, Stephanie .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (03) :568-575